Related Experiment Videos

Effect of Implementing Population-Based Prostate-Specific Antigen Screening on Testing Rates and Prostate Cancer

Andrew J Vickers1, Veeru Kasivisvanathan2,3, Adam R Brentnall4

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Summary

Implementing population-based prostate-specific antigen (PSA) screening in England could significantly reduce PSA testing and overdiagnosis by approximately 25%. This organized approach is likely to improve population health and reduce prostate cancer mortality compared to current opportunistic policies.